Ｍ－オンコリスバイオ（4588）　Phase II Clinical Trial Protocol for Telomelysin (OBP-301)-Pembrolizmab Combination Therapy to be Presented at the 2019 ASCO Annual Meeting 2019/05/30
/-
読み込み中…